Diabetes, cancer and treatment - a mini-review

Current Drug Safety

Volumn 8, Issue 5, 2013, Pages 292-295

  Vestergaard, Peter ^a   Starup Linde, Jakob ^a,b  

^a AALBORG UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Cancer risk; Diabetes mellitus; Meta analysis; Neoplasm; Systematic review

Indexed keywords

ACETYLSALICYLIC ACID; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; INSULIN DERIVATIVE; ORAL ANTIDIABETIC AGENT;

BACTERIAL FLORA; CANCER GROWTH; CANCER RISK; COFFEE; COLON CANCER; DIABETES MELLITUS; DIETARY FIBER; FRIED MEAT; GLUCOSE BLOOD LEVEL; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; INTESTINE FLORA; LIFESTYLE MODIFICATION; MEAT; NEOPLASM; OBESITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SMOKING CESSATION; SYSTEMATIC REVIEW; VIRUS INFECTION;

DIABETES COMPLICATIONS; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 2; EVIDENCE-BASED MEDICINE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; NEOPLASMS;

EID: 84891549192     PISSN: 15748863     EISSN: None     Source Type: Journal    
DOI: 10.2174/15748863113086660066     Document Type: Review

References (24)

1. Vigneri P, Frasca F, Sciacca L, et al. Diabetes and cancer. Endocr Relat Cancer 2009; 16: 1103-1123.
2. Jonasson JM, Ljung R, Talbäck M, et al. Insulin glargine use and short-term incidence of malignancies-a population-based followup study in Sweden. Diabetologia 2009; 52: 1745-1754.
3. Giovannucci E, Harlan DM, Archer MC, et al. Diabetes and cancer: a consensus report. CA Cancer J Clin 2010; 60: 207-221.
4. Wright JL, Plymate S, D'Oria-Cameron A, et al. A study of caloric restriction versus standard diet in overweight men with newly diagnosed prostate cancer: a randomized controlled trial. Prostate 2013; 73: 1345-1351.
5. Jarvandi S, Davidson NO, Schootman M. Increased risk of colorectal cancer in type 2 diabetes is independent of diet quality. PLoS One 2013; 8: e74616.
6. Gilsing AMJ, Franssen F, de Kok TM, et al. Dietary heme iron and the risk of colorectal cancer with specific mutations in KRAS and APC. Carcinogenesis 2013; in press.
7. Miller PE, Lazarus P, Lesko SM, et al. Meat-related compounds and colorectal cancer risk by anatomical subsite. Nutr Cancer 2013; 65: 202-226.
8. Wedick NM, Brennan AM, Sun Q, et al. Effects of caffeinated and decaffeinated coffee on biological risk factors for type 2 diabetes: a randomized controlled trial. Nutr J 2011; 10: 93.
9. Floegel A, Pischon T, Bergmann MM, et al. Coffee consumption and risk of chronic disease in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Germany study. Am J Clin Nutr 2012; 95: 901-908.
10. Giri A, Sturgeon SR, Luisi N, et al. Caffeinated coffee, decaffeinated coffee and endometrial cancer risk: a prospective cohort study among US postmenopausal women. Nutrients 2011; 3: 937-950.
11. Cotillard A, Kennedy SP, Kong LC, et al. Dietary intervention impact on gut microbial gene richness. Nature 2013; 500: 585-588.
12. Jarvandi S, Davidson NO, Jeffe DB, et al. Influence of lifestyle factors on inflammation in men and women with type 2 diabetes: results from the National Health and Nutrition Examination Survey, 1999-2004. Ann Behav Med 2012; 44: 399-407.
13. Dossus L, Lukanova A, Rinaldi S, et al. Hormonal, metabolic, and inflammatory profiles and endometrial cancer risk within the EPIC cohort-a factor analysis. Am J Epidemiol 2013; 177: 787-799.
14. Taniguchi CM, Finger EC, Krieg AJ, et al. Cross-talk between hypoxia and insulin signaling through Phd3 regulates hepatic glucose and lipid metabolism and ameliorates diabetes. Nat Med 2013; in press.
15. Green J, Casabonne D, Newton R. Coxsackie B virus serology and Type 1 diabetes mellitus: a systematic review of published casecontrol studies. Diabet Med 2004; 21: 507-514.
16. Gkrania-Klotsas E, Langenberg C, Tauriainen S, et al. The association between prior infection with five serotypes of Coxsackievirus B and incident type 2 diabetes mellitus in the EPIC-Norfolk study. Diabetologia 2012; 55: 967-970.
17. Wunder T, Schmid K, Wicklein D, et al. Expression of the coxsackie adenovirus receptor in neuroendocrine lung cancers and its implications for oncolytic adenoviral infection. Cancer Gene Ther 2013; 20: 25-32.
18. García-Jiménez C, Garcia-Martinez JM, Chocarro-Calvo A, et al. A new link between diabetes and cancer: enhanced Wnt/betacatenin signalling by high glucose. J Mol Endocrinol 2013; in press.
19. Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009; 324: 1029-1033.
20. Shafiee MN, Chapman C, Barrett D, et al. Reviewing the molecular mechanisms which increase endometrial cancer (EC) risk in women with polycystic ovarian syndrome (PCOS): Time for paradigm shift?. Gynecol Oncol 2013; in press.
21. Oliveras-Ferraros C, Vazquez-Martin A, Menendez JA. Genomewide inhibitory impact of the AMPK activator metformin on (kinesins, tubulins, histones, auroras and polo-like kinases) Mphase cell cycle genes in human breast cancer cells. Cell Cycle 2009; 8: 1633-1636.
22. Gronich N, Rennert G. Beyond aspirin-cancer prevention with statins, metformin and bisphosphonates. Nat Rev Clin Oncol 2013; in press.
23. Sutcliffe P, Connock M, Gurung T, et al. Aspirin for prophylactic use in the primary prevention of cardiovascular disease and cancer: a systematic review and overview of reviews. Health Technol Assess 2013; 17: 1-253.
24. Home PD, Lagarenne P. Combined randomised controlled trial experience of malignancies in studies using insulin glargine. Diabetologia 2009; 52: 2499-2506.